The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market. For the past few years, with the advent of the COVID‑19 ...

Biologics' reliance on parenteral administration limits patient compliance and accessibility, prompting exploration of non-parenteral alternatives like oral and inhaled formats. Oral and inhaled ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a U.S.-based Contract Development and Manufacturing Organization (CDMO), announced the launch of its in-house formulation development services, ...

The marcus evans 14th Edition Biologics Formulation, Development and Drug Delivery conference taking place in London, UK on 13-15 September, 2023 will explore techniques in stability formulation for ...

The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces viscosity by up to 90% while maintaining formulation ...

SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 17, 2025 / Bora Biologics is set to showcase its innovative Allosteric Formulation Platform at the Festival of Biologics 2025, demonstrating ...

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these compounds ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...